Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anthony J. Lembo, M.D.

Co-Author

This page shows the publications co-authored by Anthony Lembo and John Kelley.
Connection Strength

1.343
  1. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes. 2022 Jan-Dec; 14(1):2020067.
    View in: PubMed
    Score: 0.245
  2. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
    View in: PubMed
    Score: 0.239
  3. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010 Dec 22; 5(12):e15591.
    View in: PubMed
    Score: 0.114
  4. Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2010 Jul; 32(1):29-42.
    View in: PubMed
    Score: 0.108
  5. Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med. 2009 Sep; 71(7):789-97.
    View in: PubMed
    Score: 0.104
  6. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol. 2009 Jun; 104(6):1489-97.
    View in: PubMed
    Score: 0.102
  7. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008 May 03; 336(7651):999-1003.
    View in: PubMed
    Score: 0.094
  8. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Am J Gastroenterol. 2021 11 01; 116(11):2279-2285.
    View in: PubMed
    Score: 0.060
  9. Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2021 Jun 07.
    View in: PubMed
    Score: 0.059
  10. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.044
  11. Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients. Brain Behav. 2015 Jan; 5(1):39-44.
    View in: PubMed
    Score: 0.037
  12. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012; 7(10):e48135.
    View in: PubMed
    Score: 0.032
  13. Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterol Motil. 2010 Mar; 22(3):285-e81.
    View in: PubMed
    Score: 0.027
  14. Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. Soc Sci Med. 2010 Feb; 70(3):479-484.
    View in: PubMed
    Score: 0.026
  15. "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial. Cult Med Psychiatry. 2009 Sep; 33(3):382-411.
    View in: PubMed
    Score: 0.026
  16. Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol. 2009 Apr; 104(4):912-9.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.